BATS BZX Real-Time Price
As of 11:51am ET
| -0.025 / -0.37%|
The 8 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 12.50, with a high estimate of 31.00 and a low estimate of 6.00. The median estimate represents a +84.50% increase from the last price of 6.78.
The current consensus among 8 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.